Harry W. Herr

Defining Early Morbidity of Radical Cystectomy for Patients with Bladder Cancer Using a Standardized Reporting Methodology

Ahmad Shabsigh, Ruslan Korets, Kinjal Vora et al. · European Urology · 2008 · 1.4K citations

Standardized Reporting Methodology, Radical Cystectomy, Urology +7

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

Donald L. Lamm, A.P.M. van der Meijden, Álvaro Morales et al. · The Journal of Urology · 1992 · 783 citations

Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

Dean F. Bajorin, Paul M. Dodd, Madhu Mazumdar et al. · Journal of Clinical Oncology · 1999 · 726 citations

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

Cora N. Sternberg, Alan Yagoda, Howard I. Scher et al. · Cancer · 1989 · 673 citations

Preliminary Results of M-VAC (Methotrexate, Vinblastine, Doxorubicin and Cisplatin) for Transitional Cell Carcinoma of the Urothelium

Cora N. Sternberg, Alan Yagoda, Howard I. Scher et al. · The Journal of Urology · 1985 · 659 citations